BioCentury
ARTICLE | Clinical News

Dantrolene: Additional Phase II data

January 4, 2016 8:00 AM UTC

Additional data from the open-label, Saudi Arabian Phase II Study EGL-4104-C-1502 in 34 EHS patients showed that IV Ryanodex plus standard of care (SOC) consisting of body cooling by physical methods ...